Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids

Biophysical Journal

Volumn 100, Issue 3, 2011, Pages 646-655

  Lopez Rodriguez, Elena ^a   Echaide, Mercedes ^a   Cruz, Antonio ^a   Taeusch, H William ^b   Perez Gil, Jesus ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 79551659913     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.12.3715     Document Type: Article

References (40)

1. Been, J. V., and L. J. Zimmermann. 2007. What's new in surfactant? A clinical view on recent developments in neonatology and pediatrics. Eur. J. Pediatr. 166:889-899.
2. Nkadi, P. O., T. A. Merritt, and D.-A. M. Pillers. 2009. An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease. Mol. Genet. Metab. 97:95-101.
3. Rubin, B. K., R. P. Tomkiewicz, D. Easa. 1996. The surface and transport properties of meconium and reconstituted meconium solutions. Pediatr. Res. 40:834-838.
4. El Shahed, A. I., P. Dargaville, R. F. Soll. 2007. Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database Syst. Rev. 3: CD002054.
5. Lindenskov, P. H., A. Castellheim, O. D. Saugstad. 2005. Meconium induced IL-8 production and intratracheal albumin alleviated lung injury in newborn pigs. Pediatr. Res. 57:371-377.
6. Righetti, C., D. G. Peroni, C. Zancanaro. 2003. Proton nuclear magnetic resonance analysis of meconium composition in newborns. J. Pediatr. Gastroenterol. Nutr. 36:498-501.
7. Tølløfsrud, P. A., S. Medbø, O. D. Saugstad. 2002. Albumin mixed with meconium attenuates pulmonary dysfunction in a newborn piglet model with meconium aspiration. Pediatr. Res. 52:545-553.
8. Gunasekara, L., W. M. Schoel, M. W. Amrein. 2008. A comparative study of mechanisms of surfactant inhibition. Biochim. Biophys. Acta. 1778:433-444.
9. Zuo, Y. Y., R. A. W. Veldhuizen, F. Possmayer. 2008. Current perspectives in pulmonary surfactant-inhibition, enhancement and evaluation. Biochim. Biophys. Acta. 1778:1947-1977.
10. Fernsler, J. G., and J. A. Zasadzinski. 2009. Competitive adsorption: a physical model for lung surfactant inactivation. Langmuir. 25:8131-8143.
11. Iwanicki, J. L., K. W. Lu, and H. W. Taeusch. 2010. Hyaluronan decreases pulmonary surfactant inactivation by phospholipase A2 in vitro. Exp. Lung Res. 36:167-174.
12. Taeusch, H. W., J. Bernardino de la Serna, J. A. Zasadzinski. 2005. Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental. Biophys. J. 89:1769-1779.
13. Ravasio, A., B. Olmeda, J. Pérez-Gil. 2010. Lamellar bodies form solid three-dimensional films at the respiratory air-liquid interface. J. Biol. Chem. 285:28174-28182.
14. Rouser, G., A. N. Siakotos, and S. Fleischer. 1966. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids. 1:85-86.
15. Ravasio, A., A. Cruz, T. Haller. 2008. High-throughput evaluation of pulmonary surfactant adsorption and surface film formation. J. Lipid Res. 49:2479-2488.
16. Lowry, O. H., N. J. Rosebrough, R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
17. Cruz, A., L. A. D. Worthman, J. Pérez-Gil. 2000. Microstructure and dynamic surface properties of surfactant protein SP-B/ dipalmitoylphosphatidylcholine interfacial films spread from lipid-protein bilayers. Eur. Biophys. J. 29:204-213.
18. Wang, L., A. Cruz, R. Mendelsohn. 2007. Langmuir-Blodgett films formed by continuously varying surface pressure. Characterization by IR spectroscopy and epifluorescence microscopy. Langmuir. 23:4950-4958.
19. Schürch, S., F. H. Y. Green, and H. Bachofen. 1998. Formation and structure of surface films: captive bubble surfactometry. Biochim. Biophys. Acta. 1408:180-202.
20. Gómez-Gil, L., D. Schürch, J. Pérez-Gil. 2009. Pulmonary surfactant protein SP-C counteracts the deleterious effects of cholesterol on the activity of surfactant films under physiologically relevant compression-expansion dynamics. Biophys. J. 97:2736-2745.
21. Schoel, W. M., S. Schürch, and J. Goerke. 1994. The captive bubble method for the evaluation of pulmonary surfactant: Surface tension, area, and volume calculations. Biochim. Biophys. Acta. 1200:281-290.
22. Parasassi, T., G. De Stasio, E. Gratton. 1991. Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence. Biophys. J. 60:179-189.
23. Parasassi, T., G. De Stasio, E. Gratton. 1990. Phase fluctuation in phospholipid membranes revealed by Laurdan fluorescence. Biophys. J. 57:1179-1186.
24. Reference deleted in proof.
25. Nag, K., J. Perez-Gil, K. M. Keough. 1998. Phase transitions in films of lung surfactant at the air-water interface. Biophys. J. 74:2983-2995.
26. Discher, B. M., K. M. Maloney, S. B. Hall. 1996. Lateral phase separation in interfacial films of pulmonary surfactant. Biophys. J. 71:2583-2590.
27. Gross, T., E. Zmora, A. Berman. 2006. Lung-surfactant-meconium interaction: in vitro study in bulk and at the air-solution interface. Langmuir. 22:3243-3250.
28. Parasassi, T., M. Di Stefano, E. Gratton. 1994. Influence of cholesterol on phospholipid bilayers phase domains as detected by Laurdan fluorescence. Biophys. J. 66:120-132.
29. Bernardino de la Serna, J., G. Orädd, J. Perez-Gil. 2009. Segregated phases in pulmonary surfactant membranes do not show coexistence of lipid populations with differentiated dynamic properties. Biophys. J. 97:1381-1389.
30. Bae, C.-W., A. Takahashi, M. Sasaki. 1998. Morphology and function of pulmonary surfactant inhibited by meconium. Pediatr. Res. 44:187-191.
31. Oh, M. H., and C. W. Bae. 2000. Inhibitory effect of meconium on pulmonary surfactant function tested in vitro using the stable microbubble test. Eur. J. Pediatr. 159:770-774.
32. Park, K.-H., C.-W. Bae, and S.-J. Chung. 1996. In vitro effect of meconium on the physical surface properties and morphology of exogenous pulmonary surfactant. J. Korean Med. Sci. 11:429-436.
33. Herting, E., P. Rauprich, B. Robertson. 2001. Resistance of different surfactant preparations to inactivation by meconium. Pediatr. Res. 50:44-49.
34. Blanco, O., and J. Pérez-Gil. 2007. Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat respiratory distress syndrome: role of the different components in an efficient pulmonary surfactant. Eur. J. Pharmacol. 568:1-15.
35. Markart, P., C. Ruppert, A. Guenther. 2007. Patients with ARDS show improvement but not normalization of alveolar surface activity with surfactant treatment: putative role of neutral lipids. Thorax. 62:588-594.
36. Bernardino de la Serna, J., J. Perez-Gil, L. A. Bagatolli. 2004. Cholesterol rules: direct observation of the coexistence of two fluid phases in native pulmonary surfactant membranes at physiological temperatures. J. Biol. Chem. 279:40715-40722.
37. Orgeig, S., and C. B. Daniels. 2001. The roles of cholesterol in pulmonary surfactant: insights from comparative and evolutionary studies. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 129:75-89.
38. Gunasekara, L. C., R. M. Pratt, M. W. Amrein. 2010. Methyl-[b]- cyclodextrin restores the structure and function of pulmonary surfactant films impaired by cholesterol. Biochim. Biophys. Acta. Biomembranes. 1798:986-994.
39. Serrano, A. G., and J. Pérez-Gil. 2006. Protein-lipid interactions and surface activity in the pulmonary surfactant system. Chem. Phys. Lipids. 141:105-118.
40. Zhou, Y., R. Doyen, and L. M. Lichtenberger. 2009. The role of membrane cholesterol in determining bile acid cytotoxicity and cytoprotection of ursodeoxycholic acid. Biochim. Biophys. Acta. 1788:507-513.